SEC Filing - ChampionX Corporation

View:

Download DOC

Download PDF

Download XLS

Download XBRL

championx-20210630

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-38441

ChampionX Corporation

(Exact name of registrant as specified in its charter)


Delaware		82-3066826
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

2445 Technology Forest Blvd,	Building 4, 12th Floor
The Woodlands,	Texas	77381
(Address of principal executive offices)		(Zip Code)

(281) 403-5772

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, $0.01 par value	CHX	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☑

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

The registrant had 201,802,181 shares of common stock, $0.01 par value, outstanding as of July 23, 2021.

CHAMPIONX CORPORATION

TABLE OF CONTENTS


PART I — FINANCIAL INFORMATION		Page
Item 1.	Financial Statements (unaudited)
	Condensed Consolidated Statements of Income (Loss)	1
	Condensed Consolidated Statements of Comprehensive Income (Loss)	2
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Changes in Stockholders’ Equity	4
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
	Executive Overview and Business Outlook	23
	Consolidated Results of Operations	25
	Segment Results of Operations	27
	Capital Resources and Liquidity	29
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	30
Item 4.	Controls and Procedures	31

PART II — OTHER INFORMATION
Item 1.	Legal Proceedings	32
Item 1A.	Risk Factors	32
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	32
Item 3.	Defaults Upon Senior Securities	32
Item 4.	Mine Safety Disclosures	32
Item 5.	Other Information	32
Item 6.	Exhibits	33
SIGNATURES		34

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained in this report are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements usually relate to future events and anticipated revenues, earnings, cash flows or other aspects of our operations or operating results. Forward-looking statements are often identified by the words “believe,” “anticipate,” “expect,” “may,” “intend,” “foresee,” “guidance,” “estimate,” “potential,” “outlook,” “plan,” “should,” “would,” “could,” “target,” “forecast” and similar expressions, including the negative thereof. The absence of these words, however, does not mean that the statements are not forward-looking statements. Forward-looking statements are based on our current expectations, beliefs and assumptions concerning future developments and business conditions and their potential effect on us. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting us will be those that we anticipate.

All of our forward-looking statements involve risks, uncertainties (some of which are significant or beyond our control) and assumptions that could cause actual results to materially differ from our historical experience and our present expectations or projections. Known material factors that could cause actual results to materially differ from those contemplated in the forward-looking statements are those set forth in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

We wish to caution you not to place undue reliance on any forward-looking statements, which speak only as of the date hereof. We undertake no obligation to publicly update, revise or correct any of our forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required under the federal securities laws.

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands, except per share data)	2021		2020		2021		2020
Product revenue	$	649,399	$	248,871	$	1,234,756	$	473,316
Service revenue	81,223		36,846		161,849		61,770
Lease and other revenue	18,550		13,197		37,455		25,262
Total revenue	749,172		298,914		1,434,060		560,348
Cost of goods and services	569,167		266,684		1,091,723		445,779
Gross profit	180,005		32,230		342,337		114,569
Selling, general and administrative expense	152,341		130,657		295,819		208,800
Goodwill impairment	—		—		—		616,271
Long-lived asset impairment	—		—		—		40,980
Interest expense, net	14,064		11,262		28,035		20,301
Other (income) expense, net	2,251		312		315		(1,321)
Income (loss) before income taxes	11,349		(110,001)		18,168		(770,462)
Provision for (benefit from) income taxes	3,563		(954)		6,345		(27,960)
Net income (loss)	7,786		(109,047)		11,823		(742,502)
Less: Net income (loss) attributable to noncontrolling interest	536		598		(1,199)		871
Net income (loss) attributable to ChampionX	$	7,250	$	(109,645)	$	13,022	$	(743,373)








Earnings (losses) per share attributable to ChampionX: *
Basic	$	0.04	$	(0.95)	$	0.06	$	(7.72)
Diluted	$	0.03	$	(0.95)	$	0.06	$	(7.72)
Weighted-average shares outstanding: *
Basic	201,467		115,149		201,063		96,313
Diluted	208,541		115,149		207,939		96,313

_______________________

* See Note 11—Earnings Per Share

The accompanying notes are an integral part of the condensed consolidated financial statements.

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	2021		2020		2021		2020
Net income (loss)	$	7,786	$	(109,047)	$	11,823	$	(742,502)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	8,332		5,703		11,545		(5,349)
Cash flow hedges	(277)		653		136		653
Defined pension and other post-retirement benefits adjustments, net	6,373		99		6,540		198
Other comprehensive income (loss)	14,428		6,455		18,221		(4,498)
Comprehensive income (loss)	22,214		(102,592)		30,044		(747,000)
Comprehensive income (loss) attributable to noncontrolling interest	536		598		(1,199)		871
Comprehensive income (loss) attributable to ChampionX	$	21,678	$	(103,190)	$	31,243	$	(747,871)

The accompanying notes are an integral part of the condensed consolidated financial statements.

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)


(in thousands)	June 30, 2021		December 31, 2020
ASSETS
Cash and cash equivalents	$	238,995	$	201,421

Receivables, net	576,090		559,545
Inventories, net	467,594		430,112
Prepaid expenses and other current assets	67,360		74,767
Total current assets	1,350,039		1,265,845
Property, plant and equipment, net of accumulated depreciation of $541,796 in 2021 and $494,490 in 2020	818,928		854,536
Operating lease right-of-use assets	118,898		122,481

Goodwill	690,134		680,594
Intangible assets, net	436,027		479,009
Other non-current assets	71,984		73,311

Total assets	$	3,486,010	$	3,475,776
LIABILITIES AND EQUITY
Current portion of long-term debt	$	26,850	$	26,850
Accounts payable	391,213		299,666
Accrued compensation and employee benefits	69,315		70,303
Current portion of operating lease liabilities	35,471		33,234
Accrued distributor fees	28,813		37,465
Accrued expenses and other current liabilities	134,916		155,042
Total current liabilities	686,578		622,560
Long-term debt	838,826		905,764
Deferred income taxes	144,418		156,283
Operating lease liabilities	77,344		83,553

Other long-term liabilities	79,887		95,041
Total liabilities	1,827,053		1,863,201
Stockholders’ equity:
Common stock (2.5 billion shares authorized, $0.01 par value) 201.7 million shares and 200.4 million shares issued and outstanding in 2021 and 2020, respectively	2,017		2,004
Capital in excess of par value of common stock	2,310,267		2,293,179

Accumulated deficit	(625,435)		(638,457)
Accumulated other comprehensive loss	(12,534)		(30,755)
ChampionX stockholders’ equity	1,674,315		1,625,971
Noncontrolling interest	(15,358)		(13,396)
Total equity	1,658,957		1,612,575
Total liabilities and equity	$	3,486,010	$	3,475,776

The accompanying notes are an integral part of the condensed consolidated financial statements.

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)


	Common stock
(in thousands)	Shares	Par Value		Capital in Excess of Par Value		Accum. Deficit		Accum. Other Comp. Loss		Non-controlling Interest		Total
December 31, 2020	200,380	$	2,004	$	2,293,179	$	(638,457)	$	(30,755)	$	(13,396)	$	1,612,575
Net income (loss)	—	—		—		5,772		—		(1,735)		4,037
Other comprehensive income	—	—		—		—		3,793		—		3,793
Stock-based compensation	64	—		6,442		—		—		—		6,442
Stock options exercised	577	6		3,341		—		—		—		3,347
Taxes withheld on issuance of stock-based awards	—	—		(556)		—		—		—		(556)
Cumulative translation adjustments	—	—		—		—		—		268		268
Distributions to noncontrolling interest	—	—		—		—		—		(800)		(800)
March 31, 2021	201,021	$	2,010	$	2,302,406	$	(632,685)	$	(26,962)	$	(15,663)	$	1,629,106
Net income (loss)	—	—		—		7,250		—		536		7,786
Other comprehensive income	—	—		—		—		14,428		—		14,428
Stock-based compensation	101	—		5,914		—		—		—		5,914
Stock options exercised	578	7		3,155		—		—		—		3,162
Taxes withheld on issuance of stock-based awards	—	—		(1,208)		—		—		—		(1,208)
Cumulative translation adjustments	—	—		—		—		—		(231)		(231)


June 30, 2021	201,700	$	2,017	$	2,310,267	$	(625,435)	$	(12,534)	$	(15,358)	$	1,658,957


	Common Stock
(in thousands)	Shares	Par Value		Capital in Excess of Par Value		Retained Earnings (Accum. Deficit)		Accum. Other Comp. Loss		Non-controlling Interest		Total
December 31, 2019	77,460	$	775	$	969,174	$	107,048	$	(44,037)	$	3,254	$	1,036,214
Cumulative effect of accounting changes	—	—		—		(1,573)		—		—		(1,573)
Net income (loss)	—	—		—		(633,728)		—		273		(633,455)
Other comprehensive loss	—	—		—		—		(10,953)		—		(10,953)
Stock-based compensation	44	—		2,429		—		—		—		2,429
Taxes withheld on issuance of stock-based awards	—	—		(368)		—		—		—		(368)

March 31, 2020	77,504	$	775	$	971,235	$	(528,253)	$	(54,990)	$	3,527	$	392,294
Issuance of common stock related to the Merger	122,237	1,223		1,262,708		—		—		—		1,263,931
Issuance of replacement awards related to the Merger	—	—		43,964		—		—		—		43,964
Non-controlling interest acquired in the Merger	—	—		—		—		—		(16,015)		(16,015)
Net income (loss)	—	—		—		(109,645)		—		598		(109,047)
Other comprehensive income	—	—		—		—		6,455		—		6,455
Stock-based compensation	67	—		5,433		—		—		—		5,433
Taxes withheld on issuance of stock-based awards	—	—		(244)		—		—		—		(244)
Distributions to noncontrolling interest	—	—		—		—		—		(2,200)		(2,200)
Other	—	—		—		37		—		(12)		25
June 30, 2020	199,808	$	1,998	$	2,283,096	$	(637,861)	$	(48,535)	$	(14,102)	$	1,584,596

The accompanying notes are an integral part of the condensed consolidated financial statements.

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	Six Months Ended June 30,
(in thousands)	2021		2020
Cash flows from operating activities:
Net income (loss)	$	11,823	$	(742,502)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:

Depreciation	76,648		58,139
Amortization	43,739		26,274
Stock-based compensation	12,356		7,862
Loss on disposal of fixed assets	3,176		4,040
Loss on goodwill and long-lived asset impairment	—		657,251

Loss on debt extinguishment	3,305		—
Provision for bad debt	86		3,498
Provision for inventory obsolescence and write-downs	6,200		8,354
Amortization of deferred loan costs and accretion of discount	1,628		1,999
Deferred income taxes	(1,757)		(24,682)
Employee benefit plan expense	1,250		859
Other	167		(264)
Changes in operating assets and liabilities (net of effects of foreign exchange):
Receivables	(18,706)		77,777
Inventories	(41,586)		24,794
Prepaid expenses and other current assets	9,215		22,088
Accounts payable	92,997		(30,331)
Accrued compensation and employee benefits	(2,444)		(13,846)
Accrued expenses and other liabilities	(46,447)		4,717

Leased assets	(1,609)		(9,311)
Other	1,097		1,317
Net cash provided by operating activities	151,138		78,033

Cash flows from investing activities:
Capital expenditures	(45,680)		(19,322)
Acquisitions, net of cash acquired	—		57,588
Proceeds from sale of fixed assets	2,482		1,066

Net cash (used for) provided by investing activities	(43,198)		39,332

Cash flows from financing activities:
Proceeds from long-term debt	—		125,000
Payment of debt issue costs	—		(4,356)
Repayment of long-term debt	(71,113)		(125,000)
Distributions to noncontrolling interest	(800)		(2,200)
Payment of finance lease obligations	(2,575)		(2,802)
Proceeds from exercise of stock options	6,509		—
Payments related to taxes withheld on stock-based compensation	(1,764)		(612)
Net cash used for financing activities	(69,743)		(9,970)






Effect of exchange rate changes on cash and cash equivalents	(623)		(790)

Net increase (decrease) in cash and cash equivalents	37,574		106,605
Cash and cash equivalents at beginning of period	201,421		35,290
Cash and cash equivalents at end of period	$	238,995	$	141,895

The accompanying notes are an integral part of the condensed consolidated financial statements.

CHAMPIONX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1—BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Description of the Business

ChampionX Corporation is a global leader in chemistry solutions and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely and efficiently around the world. Our products provide efficient functioning throughout the lifecycle of a well with a focus on the production phase of wells.

Unless the context requires otherwise, references in this report to “we,” “us,” “our,” “the Company,” or “ChampionX” mean ChampionX Corporation, together with our subsidiaries where the context requires.

On June 3, 2020, the Company and Ecolab Inc. (“Ecolab”) completed a Reverse Morris Trust transaction in which we acquired the Chemical Technologies business (“the Merger”). In association with the completion of the Merger, the Company changed its name from Apergy Corporation (“Apergy”) to ChampionX Corporation.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2021.

Significant Accounting Policies

Please refer to "Note 1–Basis of Presentation and Summary of Significant Accounting Policies," to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 for the discussion of our significant accounting policies.

New Accounting Standards

All new accounting pronouncements that have been issued but not yet effective are currently being evaluated and at this time are not expected to have a material impact on our financial position or results of operations.

NOTE 2—MERGER TRANSACTION

On June 3, 2020 we completed the acquisition of the Chemical Technologies business. To complete the acquisition, we issued 122.2 million shares of common stock, at a share price of $10.34 per share, in exchange for 100% equity ownership of Chemical Technologies.

Purchase Price Allocation

The acquisition-date fair value of the consideration transferred consisted of the following:


(in thousands)
Equity consideration	$	1,263,931
Replacement awards attributable to pre-combination services(1)	43,964
Unfavorable supply agreement(2)	46,000
Favorable supply agreement(2)	(59,000)
Fair value of consideration transferred	$	1,294,895

_______________________

(1) Represents the fair value of the replacement equity awards to the extent services were provided by employees of Chemical Technologies prior to closing.

(2) As part of the Merger, the Company entered into a Cross Supply and Product Transfer Agreement with Ecolab in which over a period of approximately three years from the merger date, certain products will be manufactured by one party for the other. The cross selling prices in which each party will transfer their products, and include a take-or-pay element, have been set forth within this agreement and are not reflective of market terms. As a result, we recognized an intangible asset recorded at fair value for the favorable terms and a liability recorded at fair value for the unfavorable terms. The intangible asset will be amortized on a straight-line basis over a three-year period into cost of goods and services and the liability will be amortized as a component of product revenue.

The following table provides the final allocation of the purchase price as of the acquisition date.


(in thousands)
Cash and cash equivalents	$	57,588
Receivables	394,432
Inventories	340,000
Prepaid expenses and other current assets	63,576
Property, plant, and equipment	687,085
Identifiable intangible assets(1)	290,000
Other non-current assets	156,427
Total identifiable assets acquired	1,989,108
Accounts payable	184,028
Other current liabilities(1)	172,997
Long-term debt (2)	537,000
Deferred tax liabilities	103,956
Other liabilities(1)	98,970
Total liabilities assumed	1,096,951
Net identifiable assets acquired	892,157
Add: Negative fair value of non-controlling interests	16,052
Goodwill	386,686
Total net assets acquired	$	1,294,895

_______________________

(1) The fair value of the consideration transferred related to the favorable and unfavorable terms of the cross supply agreement has been excluded.

(2) In connection with the Merger, we assumed a term loan from Chemical Technologies, of which approximately $26.9 million has been classified as short-term representing the mandatory amortization payments due within the next twelve months. See Note 6—Debt for further information.

Pro forma financial information

The following unaudited pro forma results of operations have been prepared as though the Merger was completed on January 1, 2019. Pro forma amounts are based on the preliminary purchase price allocation of the acquisition and are not necessarily indicative of results that may be reported in the future. Non-recurring pro forma adjustments including acquisition-related costs directly attributable to the Merger are included within the reported pro forma revenue and net income (loss).


	Three Months Ended June 30,		Six Months Ended June 30,
(in thousands, except per share data)	2020		2020
Revenues	$	614,684	$	1,435,379
Net income (loss) attributable to ChampionX	(60,100)		(794,525)

Included in the net income (loss) attributable to ChampionX on a pro forma basis were goodwill and long-lived asset impairment charges of $805.0 million during the six months ended June 30, 2020.

NOTE 3—SEGMENT INFORMATION

Our reporting segments are:

•Production Chemical Technologies—provides oil and natural gas production and midstream markets with solutions to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment and a host of water-related issues.

•Production & Automation Technologies—designs, manufactures, markets and services a full range of artificial lift equipment, end-to-end digital automation solutions, as well as other production equipment and asset monitoring technologies. Production & Automation Technologies’ products are sold under a collection of brands including Harbison-Fischer, Norris, Alberta Oil Tool, Oil Lift Technology, PCS Ferguson, Pro-Rod, Upco, Unbridled ESP, Norriseal-Wellmark, Quartzdyne, Spirit, Theta, Timberline and Windrock.

•Drilling Technologies—designs, manufactures and markets polycrystalline diamond cutters and bearings for use in oil and gas drill bits under the US Synthetic brand.

•Reservoir Chemical Technologies—manufactures specialty products that support well stimulation, construction (including drilling and cementing) and remediation needs in the oil and natural gas industry.

Business activities that do not meet the criteria of an operating segment have been combined into Corporate and other. Corporate and other includes (i) corporate and overhead expenses, and (ii) revenue and costs for activities that are not operating segments.

Segment revenue and segment operating profit were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	2021		2020		2021		2020
Segment revenue:
Production Chemical Technologies	$	447,049	$	136,002	$	859,420	$	136,002
Production & Automation Technologies	188,173		114,741		355,018		320,220
Drilling Technologies	37,589		20,948		72,583		76,903
Reservoir Chemical Technologies	33,222		9,306		63,113		9,306
Corporate and other (1)	43,139		17,917		83,926		17,917
Total revenue	$	749,172	$	298,914	$	1,434,060	$	560,348

Segment operating profit (loss):
Production Chemical Technologies	$	33,871	$	9,922	$	64,228	$	9,922
Production & Automation Technologies	12,292		(37,168)		17,654		(685,759)
Drilling Technologies	3,868		(3,811)		10,254		7,548
Reservoir Chemical Technologies	(2,594)		(2,811)		(5,822)		(2,811)
Total segment operating profit (loss)	47,437		(33,868)		86,314		(671,100)
Corporate and other (1)	22,024		64,871		40,111		79,061
Interest expense, net	14,064		11,262		28,035		20,301
Income (loss) before income taxes	$	11,349	$	(110,001)	$	18,168	$	(770,462)

_______________________

(1) Corporate and other includes costs not directly attributable or allocated to our reporting segments such as corporate executive management and other administrative functions, and the results attributable to our noncontrolling interest. Additionally, the sales and expenses related to the Cross Supply Agreement with Ecolab are included within Corporate and other. See Note 2—Merger Transaction for further information.

NOTE 4—REVENUE

Our revenue is generated primarily from product sales. Service revenue is generated from providing services to our customers. These services include installation, repair and maintenance, laboratory and logistics services, chemical management services, troubleshooting, reporting, water treatment services, technical advisory assistance, asset monitoring, and other field services. Lease revenue is derived from rental income of leased production equipment. These lease arrangements generally allow customers to rent equipment on a daily basis with no stated end date. Management accounts for these arrangements as a daily renewal option beginning on the lease commencement date, with the lease term determined as the period in which it is reasonably certain the option will be exercised. As our costs are shared across the various revenue categories, cost of goods sold is not tracked separately and is not discretely identifiable.

Revenue disaggregated by geography was as follows:


	Three Months Ended June 30, 2021
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate		Total
United States	$	156,852	$	141,799	$	30,392	$	19,589	$	30,225	$	378,857
Latin America	93,389		4,530		—		3,587		1,261		102,767
Middle East & Africa	66,213		13,358		1,446		6,534		1,945		89,496
Canada	63,639		14,754		1,986		377		124		80,880
Europe	41,046		1,790		2,278		1,101		3,690		49,905
Asia-Pacific	10,562		2,743		853		1,393		5,894		21,445
Australia	5,994		9,182		13		30		—		15,219
Other	9,354		17		621		611		—		10,603
Total revenue	$	447,049	$	188,173	$	37,589	$	33,222	$	43,139	$	749,172


	Six Months Ended June 30, 2021
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate		Total
United States	$	306,716	$	267,712	$	55,799	$	35,198	$	56,242	$	721,667
Latin America	165,005		9,172		—		6,606		2,692		183,475
Middle East & Africa	124,583		24,091		2,162		12,596		7,067		170,499
Canada	124,931		27,282		5,813		1,106		282		159,414
Europe	83,654		3,773		4,777		2,490		5,947		100,641
Asia-Pacific	21,054		4,206		2,406		2,513		11,696		41,875
Australia	12,389		18,758		130		84		—		31,361
Other	21,088		24		1,496		2,520		—		25,128
Total revenue	$	859,420	$	355,018	$	72,583	$	63,113	$	83,926	$	1,434,060


	Three Months Ended June 30, 2020
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate		Total
United States	$	41,753	$	83,153	$	13,894	$	4,275	$	11,932	$	155,007
Middle East & Africa	28,148		10,262		82		2,887		2,436		43,815
Latin America	25,035		3,154		—		488		490		29,167
Europe	17,144		1,318		1,904		273		1,227		21,866
Canada	15,961		3,998		443		131		62		20,595
Australia	1,884		12,313		23		11		—		14,231
Asia-Pacific	3,692		1,295		4,170		273		1,770		11,200
Other	2,385		(752)		432		968		—		3,033
Total revenue	$	136,002	$	114,741	$	20,948	$	9,306	$	17,917	$	298,914


	Six Months Ended June 30, 2020
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate		Total
United States	$	41,753	$	237,581	$	54,834	$	4,275	$	11,932	$	350,375
Middle East & Africa	28,148		22,166		540		2,887		2,436		56,177
Canada	15,961		17,122		5,271		131		62		38,547
Latin America	25,035		10,714		22		488		490		36,749
Europe	17,144		7,658		7,595		273		1,227		33,897
Australia	1,884		21,535		69		11		—		23,499
Asia-Pacific	3,692		3,272		7,678		273		1,770		16,685
Other	2,385		172		894		968		—		4,419
Total revenue	$	136,002	$	320,220	$	76,903	$	9,306	$	17,917	$	560,348

Revenue is attributed to regions based on the location of our direct customer, which in some instances is an intermediary and not necessarily the end user.

Contract balances

Contract assets and contract liabilities from contracts with customers were as follows:


(in thousands)	June 30, 2021		December 31, 2020

Contract liabilities - current	$	15,854	$	16,668

NOTE 5—INTANGIBLE ASSETS AND GOODWILL

Intangible Assets

The components of our definite- and indefinite-lived intangible assets were as follows:


	June 30, 2021						December 31, 2020
(in thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Definite-lived intangible assets:
Customer relationships	$	594,549	$	343,941	$	250,608	$	593,068	$	321,298	$	271,770
Unpatented technologies	133,700		28,652		105,048		133,700		19,958		113,742
Favorable supply agreements	59,000		20,927		38,073		59,000		11,308		47,692
Trademarks	59,878		30,045		29,833		59,881		27,565		32,316
Patents	38,863		30,368		8,495		38,635		29,289		9,346
Other	5,422		5,052		370		5,374		4,831		543
	891,412		458,985		432,427		889,658		414,249		475,409
Indefinite-lived intangible assets:
Trademarks	3,600		—		3,600		3,600		—		3,600
Total	$	895,012	$	458,985	$	436,027	$	893,258	$	414,249	$	479,009

Goodwill

We perform our annual goodwill impairment test for two of our reporting units (i) Production Chemical Technologies and (ii) Reservoir Chemical Technologies as of May 31 of each fiscal year. During the second quarter of 2021, we completed our assessment and concluded that the goodwill related to those reporting units was not impaired.

NOTE 6—DEBT

Long-term debt consisted of the following:


(in thousands)	June 30, 2021		December 31, 2020
2018 Credit Facility	$	—	$	—
2018 Term Loan Facility	140,000		140,000
2020 Term Loan Facility	510,150		523,575
6.375% Senior Notes due 2026	222,041		277,041
Total	872,191		940,616
Net unamortized discounts and issuance costs	(6,515)		(8,002)
Total long-term debt	$	865,676	$	932,614
Current portion of long-term debt (1)	(26,850)		(26,850)
Long-term debt, less current portion	$	838,826	$	905,764

_______________________

(1) Represents the mandatory amortization payments due within twelve months related to the 2020 Term Loan Facility.

The 2020 Term Loan Facility is subject to mandatory amortization payments of $6.7 million paid quarterly, which began on September 30, 2020, and contains customary representations and warranties, covenants, and events of default for loan facilities of this type. We were in compliance with all covenants as of June 30, 2021. The weighted average interest rate on borrowings during the six month period ended June 30, 2021 was 2.63% and 6.00% for the 2018 Term Loan Facility and 2020 Term Loan Facility, respectively.

Tender Offer

On May 7, 2021, the Company completed a tender offer to purchase certain of the Senior Notes (the “Tender Offer”) at 104.781%. We repurchased $55.0 million in aggregate principal amount of the Senior Notes for $57.7 million in cash, including principal, and $0.1 million in accrued interest. In connection with these repurchases, we recognized a net loss of approximately $3.3 million for the period ended June 30, 2021, inclusive of the write off of unamortized debt financing costs related to the extinguished portion of the notes, and is included in other expense, net in our condensed consolidated statement of income (loss).

NOTE 7—COMMITMENTS AND CONTINGENCIES

The Company is subject to various claims and contingencies related to, among other things, workers’ compensation, general liability (including product liability), automobile claims, health care claims, environmental matters, and lawsuits. We record liabilities where a contingent loss is probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. In accordance with applicable GAAP, the Company discloses a contingent liability even if the liability is not probable or the amount is not estimable, or both, if there is a reasonable possibility that a material loss may have been incurred.

Guarantees and Indemnifications

We have provided indemnities in connection with sales of certain businesses and assets, including representations and warranties, covenants and related indemnities for environmental health and safety, tax, and employment matters. We do not have any material liabilities recorded for these indemnifications and are not aware of any claims or other information that would give rise to material payments under such indemnities.

In connection with the Company’s separation from Dover Corporation (“Dover”) in 2018, we entered into agreements with Dover that govern the treatment between Dover and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Dover’s business with Dover. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters. In addition, pursuant to the tax matters agreement, we have agreed to indemnify Dover and its affiliates against any and all tax-related liabilities incurred by them relating to the separation

and/or certain related transactions to the extent caused by an acquisition of ChampionX stock or assets or by any other action or failure to act undertaken by ChampionX or its affiliates.

In connection with the Merger, we entered into agreements with Ecolab that govern the treatment between Ecolab and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Ecolab’s business with Ecolab. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters. In addition, pursuant to the Tax Matters Agreement, we have agreed to indemnify Ecolab and its affiliates for (i) all taxes for which ChampionX is responsible as defined within the Tax Matters Agreement, (ii) all taxes resulting from a breach by ChampionX of any of its representations (but only to the extent relating to a breach occurring after the consummation of the Merger) or any of its covenants under the Tax Matters Agreement, (iii) all taxes resulting from an acquisition after the Merger of any of the stock or assets of ChampionX, other than as a result of the Merger or a repayment of the ChampionX Credit Facilities and (iv) reasonable costs and expenses (including reasonable attorneys’ fees and expenses) related to the foregoing.

As of June 30, 2021 and December 31, 2020, we had $85.3 million and $88.8 million, respectively, of outstanding letters of credit, surety bonds and guarantees which expire at various dates through 2027. These financial instruments are primarily maintained as security for insurance, warranty, and other performance obligations. Generally, we would only be liable for the amount of these letters of credit and surety bonds in the event of default in the performance of our obligations, the probability of which we believe is remote.

Litigation and Environmental Matters

We are involved in various pending or potential lawsuits, claims and environmental actions that have arisen in the ordinary course of our business. These proceedings primarily involve claims by private parties alleging injury arising out of use of our products, patent infringement, employment matters, and commercial disputes, as well as possible obligations to investigate and mitigate the effects on the environment of the disposal or release of certain chemical substances at various sites, such as Superfund sites and either operating or owned facilities. We review the probable outcome of such proceedings, the costs and expenses reasonably expected to be incurred and accrued to date, and the availability and extent of insurance coverage. We accrue a liability for legal matters that are probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. We are unable to predict the ultimate outcome of these actions because of the inherent uncertainty of litigation and unfavorable rulings or developments could occur, and there can be no certainty that the Company may not ultimately incur changes in excess of recorded liabilities. However, we believe the most probable, ultimate resolution of these matters will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

Environmental Matters

The Company is currently participating in environmental assessments and remediation at approximately 11 locations, the majority of which are in the U.S., and environmental liabilities have been accrued reflecting our best estimate of future costs. Potential insurance reimbursements are not anticipated in the Company’s accruals for environmental liabilities. As of June 30, 2021 environmental liability accruals related to these locations were $7.4 million.

Prior to the separation from Dover in 2018, groundwater contamination was discovered at the Norris Sucker Rods plant site located in Tulsa, Oklahoma ("Norris"). Initial remedial efforts were undertaken at the time of discovery of the contamination and Norris has since coordinated monitoring and remediation with the Oklahoma Department of Environmental Quality ("ODEQ"). As part of the ongoing long-term remediation process, Norris contracted an engineering and consulting firm to develop a range of possible additional remedial alternatives in order to accelerate the remediation process and associated cost estimates for the work. In October 2019, we received the firm’s preliminary remedial alternatives for consideration. We have submitted our long-term remediation plan and it was approved by ODEQ. We are now in discussion with ODEQ to finalize a consent order. Because we have not yet finalized the consent order for further remediation at the site and discussions with ODEQ remain ongoing, we cannot fully anticipate the timing, outcome or possible impact of such further remedial activities, financial or otherwise. As a result of the recommendations in the report, we accrued liabilities for these remediation efforts of approximately $2.0 million as of December 31, 2020. Liabilities could increase in the future at such time as we ultimately reach agreement with ODEQ on our remediation plan and such liabilities become probable and can be reasonably estimated, however, there have been no changes to our estimated liability as of June 30, 2021.

Matters Related to Deepwater Horizon Incident Response

On April 22, 2010, the deepwater drilling platform, the Deepwater Horizon, operated by a subsidiary of BP plc, sank in the Gulf of Mexico after an explosion and fire, resulting in a massive oil spill. Certain entities that are now subsidiaries of ChampionX as a result of the Merger (collectively the “COREXIT Defendants”) supplied COREXIT™ 9500, an oil dispersant product listed on the U.S. EPA National Contingency Plan Product Schedule, which was used in the response to the spill. In connection with the provision of COREXIT™, the COREXIT Defendants were named in several lawsuits. Cases arising out of the Deepwater Horizon accident were administratively transferred and consolidated for pre-trial purposes under In Re: Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010, Case No. 10-md-02179 in the United States District Court in the Eastern District of Louisiana (E.D. La.) (“MDL 2179”). Claims related to the response to the oil spill were consolidated in a master complaint captioned the “B3 Master Complaint.” In 2011, Transocean Deepwater Drilling, Inc. and its affiliates (the “Transocean Entities”) named the COREXIT Defendants and other unaffiliated companies as first party defendants (In re the Complaint and Petition of Triton Asset Leasing GmbH, et al, MDL No. 2179, Civil Action 10-2771). In April and May 2011, the Transocean Entities, Cameron International Corporation, Halliburton Energy Services, Inc., M-I L.L.C., Weatherford U.S., L.P. and Weatherford International, Inc. (collectively, the “Cross Claimants”) filed cross claims in MDL 2179 against the COREXIT Defendants and other unaffiliated cross defendants. In April and June 2011, in support of its defense of the claims against it, the COREXIT Defendants filed counterclaims against the Cross Claimants. On May 18, 2012, the COREXIT Defendants filed a motion for summary judgment as to the claims in the B3 Master Complaint. On November 28, 2012, the Court granted the COREXIT Defendants’ motion and dismissed with prejudice the claims in the B3 Master Complaint asserted against the COREXIT Defendants. There currently remain three “B3” cases that had asserted claims against Nalco and that remain pending against other defendants. Because the Court’s decision was not a “final judgment” for purposes of appeal with respect to those claims, under Federal Rule of Appellate Procedure 4(a), plaintiffs will have 30 days after entry of final judgment in each case to appeal the Court’s summary judgment decision.

The Company believes the claims asserted against the COREXIT Defendants are without merit and intends to defend these lawsuits vigorously. The Company also believes that it has rights to contribution and/or indemnification (including legal expenses) from third parties. However, we cannot predict the outcome of these lawsuits, the involvement it might have in these matters in the future, or the potential for future litigation.

NOTE 8—RESTRUCTURING AND OTHER RELATED CHARGES

During the current and prior periods, we approved various restructuring plans related to the consolidation of product lines and associated facility closures and workforce reductions. As a result, we recognized charges of $3.8 million and $8.0 million during the three and six months ended June 30, 2021, respectively, consisting of employee severance and related benefits. During the three and six months ended June 30, 2020, we recorded restructuring and other charges of $12.1 million and $14.9 million, respectively.

The following table presents the restructuring and other related charges by segment as classified in our condensed consolidated statements of income (loss).


	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	2021		2020		2021		2020
Segment restructuring charges:
Production Chemical Technologies	$	3,103	$	—	$	3,791	$	—
Production & Automation Technologies	432		8,334		3,956		9,005
Drilling Technologies	—		3,426		—		5,521
Reservoir Chemical Technologies	198		—		242		—
Corporate	42		368		42		368
Total	$	3,775	$	12,128	$	8,031	$	14,894

Statements of Income (Loss) classification:
Cost of goods and services	$	422	$	8,707	$	3,906	$	10,746
Selling, general and administrative expense	3,353		3,421		4,125		4,148
Total	$	3,775	$	12,128	$	8,031	$	14,894

Our liability balance for restructuring and other related charges at June 30, 2021, reflects employee severance and related benefits initiated during the period. Additional programs may be initiated during 2021 with related restructuring charges.

The following table details our restructuring accrual activities during the six months ended June 30, 2021:


(in thousands)	Restructuring Accrual Balance
December 31, 2020	$	2,951
Restructuring charges	6,035
Payments	(2,915)
Other, including foreign currency translation	(4)
June 30, 2021	$	6,067

NOTE 9—EQUITY AND CASH INCENTIVE PROGRAMS

Stock-based compensation expense is reported within selling, general and administrative expense in the condensed consolidated statements of income (loss). Stock-based compensation expense relating to all stock-based incentive plans was as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	2021		2020		2021		2020
Stock-based compensation expense	$	5,914	$	5,433	$	12,356	$	7,862
Tax benefit	(1,242)		(1,203)		(2,595)		(1,802)
Stock-based compensation expense, net of tax	$	4,672	$	4,230	$	9,761	$	6,060

A summary of activity relating to our share-based awards for the six months ended June 30, 2021, was as follows:


(in shares)	Stock-Settled Appreciation Rights	Performance Share Awards	Restricted Stock Units	Non-Qualified Stock Options
Outstanding at January 1, 2021	415,331	278,763	2,669,779	7,175,040
Granted	—	333,037	842,148	—
Forfeited	(2,134)	—	(94,371)	(59,963)
Exercised / vested	(10,000)	—	(236,250)	(1,155,492)
Outstanding at June 30, 2021	403,197	611,800	3,181,306	5,959,585

NOTE 10—ACCUMULATED OTHER COMPREHENSIVE LOSS

Accumulated other comprehensive loss—Accumulated other comprehensive loss consisted of the following:


(in thousands)	Foreign Currency Translation		Defined Pension and Other Post-Retirement Benefits		Cash Flow Hedges		Accumulated Other Comprehensive Loss
December 31, 2020	$	(14,965)	$	(13,470)	$	(2,320)	$	(30,755)
Other comprehensive loss before reclassifications, net of tax	3,213		—		413		3,626
Reclassification adjustment for net losses included in net income, net of tax	—		167		—		167
Other comprehensive income (loss), net of tax	3,213		167		413		3,793
March 31, 2021	$	(11,752)	$	(13,303)	$	(1,907)	$	(26,962)
Other comprehensive income before reclassifications, net of tax	8,332		—		(277)		8,055
Reclassification adjustment for net losses included in net income, net of tax	—		6,373		—		6,373
Other comprehensive income, net of tax	8,332		6,373		(277)		14,428
June 30, 2021	$	(3,420)	$	(6,930)	$	(2,184)	$	(12,534)


(in thousands)	Foreign Currency Translation		Defined Pension and Other Post-Retirement Benefits		Cash Flow Hedges		Accumulated Other Comprehensive Loss
December 31, 2019	$	(35,210)	$	(8,827)	$	—	$	(44,037)
Other comprehensive income (loss) before reclassifications, net of tax	(11,052)		—		—		(11,052)
Reclassification adjustment for net losses included in net income, net of tax	—		99		—		99
Other comprehensive income, net of tax	(11,052)		99		—		(10,953)
March 31, 2020	$	(46,262)	$	(8,728)	$	—	$	(54,990)
Other comprehensive income (loss) before reclassifications, net of tax	5,703		—		653		6,356
Reclassification adjustment for net losses included in net income, net of tax	—		99		—		99
Other comprehensive income (loss), net of tax	5,703		99		653		6,455
June 30, 2020	$	(40,559)	$	(8,629)	$	653	$	(48,535)

Reclassifications from accumulated other comprehensive loss—Reclassification adjustments from accumulated other comprehensive loss to net income (loss) related to defined pension and other post-retirement benefits consisted of the following:


	Three Months Ended June 30,				Six Months Ended June 30,				Affected line items on the condensed consolidated statements of income (loss)
(in thousands)	2021		2020		2021		2020
Pensions and other post-retirement benefits:
Amortization of actuarial loss and other	$	6,326	$	132	$	6,540	$	264	Other (income) expense, net

Total before tax	6,326		132		6,540		264		Income (loss) before income taxes
Tax benefit	47		(33)		—		(66)		Provision for (benefit from) income taxes
Net of tax	$	6,373	$	99	$	6,540	$	198	Net income (loss)

NOTE 11—EARNINGS PER SHARE

A reconciliation of the number of shares used for the basic and diluted earnings (loss) per share calculation was as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands, except per share data)	2021		2020		2021		2020
Net income (loss) attributable to ChampionX	$	7,250	$	(109,645)	$	13,022	$	(743,373)

Weighted-average number of shares outstanding	201,467		115,149		201,063		96,313
Dilutive effect of stock-based compensation	7,074		—		6,876		—
Total shares and dilutive securities	208,541		115,149		207,939		96,313

Basic earnings (loss) per share attributable to ChampionX	$	0.04	$	(0.95)	$	0.06	$	(7.72)
Diluted earnings (loss) per share attributable to ChampionX	$	0.03	$	(0.95)	$	0.06	$	(7.72)

For all periods presented, the computation of diluted earnings (losses) per share excludes awards with an anti-dilutive impact. For the three and six months ended June 30, 2021, the diluted shares include the dilutive impact of equity awards except for approximately 0.7 million and 0.7 million shares, respectively, that were excluded because their inclusion would be anti-dilutive. For the three and six months ended June 30, 2020, we excluded all outstanding equity awards from the calculation of weighted-average shares outstanding, because their inclusion would be anti-dilutive as we were in a loss position.

NOTE 12—FAIR VALUE MEASUREMENTS

Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels:

Level 1- Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.

Level 2- Inputs include observable inputs other than quoted prices in active markets.

Level 3- Inputs are unobservable inputs for which there is little or no market data available.

The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows:


	June 30, 2021		December 31, 2020
(in thousands)	Carrying Amount
Assets
Foreign currency forward contracts	$	3,856	$	4,576

Liabilities
Foreign currency forward contracts	$	5,961	$	6,561

The carrying value of foreign currency forward contracts is at fair value, which is determined based on foreign currency exchange rates as of the balance sheet date and is classified within Level 2. For purposes of fair value disclosure above, derivative values are presented gross. See Note 13—Derivatives And Hedging Transactions for further discussion of gross versus net presentation of the Company’s derivatives.

The carrying amounts of cash and cash equivalents, trade receivables, accounts payable, as well as amounts included in other current assets and other current liabilities that meet the definition of financial instruments, approximate fair value due to their short-term nature.

The fair value of our senior notes is based on Level 1 quoted market prices. The fair value of our term loan facilities are based on Level 2 quoted market prices for the same or similar debt instruments. The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were:


	June 30, 2021				December 31, 2020
(in thousands)	Carrying Amount		Fair Value		Carrying Amount		Fair Value
2018 Term Loan Facility	$	140,000	$	138,950	$	140,000	$	137,200
2020 Term Loan Facility	$	510,150	$	516,527	$	523,575	$	530,120
6.375% Senior Notes due 2026	$	222,041	$	232,566	$	277,041	$	277,054

NOTE 13—DERIVATIVES AND HEDGING TRANSACTIONS

The Company uses foreign currency forward contracts to manage risks associated with foreign currency exchange rates. The Company does not hold derivative financial instruments of a speculative nature or for trading purposes. Derivative contracts are recorded as assets and liabilities on the balance sheet at fair value. We evaluate hedge effectiveness at contract inception and thereafter on a quarterly basis. If a derivative is no longer expected to be effective, hedge accounting is discontinued. Changes in fair value are recognized immediately in earnings unless the derivative qualifies and is designated as a hedge. Changes in fair value attributable to changes in spot exchange rates for derivative contracts that have been designated as cash flow hedges are recognized in accumulated other comprehensive income (loss) (“AOCI”) and reclassified into earnings in the same period the hedged transaction affects earnings and are presented in the same income statement line as the earnings effect of the hedged item. Cash flows from derivatives are classified in the statement of cash flows in the same category as the cash flows from the items subject to designated hedge or undesignated (economic) hedge relationships.

The Company is exposed to credit risk in the event of nonperformance of counterparties for foreign currency forward exchange contracts. We monitor our exposure to credit risk by using major global banks and financial institutions as counterparties and monitoring their financial condition and credit profile. The Company does not anticipate nonperformance by any of these counterparties, and therefore, recording a valuation allowance against the Company’s derivative balance is not considered necessary.

Derivative Positions Summary

Certain of the Company’s derivative transactions are subject to master netting arrangements that allow the Company to settle with the same counterparties. These arrangements generally do not call for collateral and as of the applicable dates presented in the following table, no cash collateral had been received or pledged related to the underlying derivatives. We have elected to present our derivative balances on a gross basis on the condensed consolidated balance sheet.

The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet.


	Derivative Assets				Derivative Liabilities
(in thousands)	June 30, 2021		December 31, 2020		June 30, 2021		December 31, 2020
Prepaid expenses and other current assets	$	3,856	$	4,576	$	—	$	—
Accrued expenses and other current liabilities	—		—		5,961		$	6,561
	$	3,856	$	4,576	$	5,961	$	6,561

The following table summarizes the notional values of the Company’s outstanding derivatives:


(in thousands)	June 30, 2021		December 31, 2020
Notional value of foreign currency forward contracts	$	568,929	$	483,377

Cash Flow Hedges

The Company utilizes foreign currency forward contracts to hedge the effect of foreign currency exchange rate fluctuations on forecasted foreign currency transactions, primarily related to inventory purchases. These forward contracts are designated as cash flow hedges. The changes in fair value of these contracts attributable to changes in spot exchange rates are recorded in AOCI until the hedged items affect earnings, at which time the gain or loss is reclassified into the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged. The forward points are marked-to-market monthly and recognized in the same line item in the condensed consolidated statement of income (loss) as the underlying exposure being hedged.

Derivatives Not Designated as Hedging Instruments

The Company also uses foreign currency forward contracts to offset its exposure to the change in value of certain foreign currency denominated assets and liabilities, primarily receivables and payables, which are remeasured at the end of each period. Although the contracts are effective economic hedges, they are not designated as accounting hedges. Therefore, changes in the value of these derivatives are recognized immediately in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities.

Effect of Derivative Instruments on Income

The loss of all derivative instruments recognized is summarized below:


	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	2021		2020		2021		2020
Loss reclassified from AOCI to income on cash flow hedges:
Cost of goods and services	$	1,018	$	15	$	1,772	$	15

Loss on derivatives not designated as hedging instruments:
Other (income) expense, net	795		711		1,462		711

Total loss of derivative instruments	$	1,813	$	726	$	3,234	$	726

NOTE 14—INVENTORIES

Inventories consisted of the following:


(in thousands)	June 30, 2021		December 31, 2020
Raw materials	$	155,054	$	137,038
Work in progress	13,064		9,509
Finished goods	364,789		323,144
	532,907		469,691
Inventory reserve	(29,968)		(24,769)
LIFO adjustments (1)	(35,345)		(14,810)
Inventories, net	$	467,594	$	430,112

_______________________

(1) Represents the amount by which LIFO inventories exceeded their carrying value.

NOTE 15—CASH FLOW INFORMATION

Lease program

Our ESP leased asset program is reported in our Production & Automation Technologies segment. At the time of purchase, assets are recorded to inventory and are transferred to property, plant, and equipment when a customer contracts for an asset under our lease program. During the six months ended June 30, 2021 and June 30, 2020, we transferred $20.3 million and $12.4 million, respectively, of inventory into property, plant, and equipment as a result of assets entering our leased asset program.

Expenditures for assets that are placed into our leased asset program expected to be recovered through sale are reported in leased assets in the operating section of our condensed consolidated statements of cash flows. All other capitalizable expenditures for assets that are placed into our leased asset program are classified as capital expenditures in the investing section of our condensed consolidated statements of cash flows.

NOTE 16—SUBSEQUENT EVENTS

On July 2, 2021, we acquired Scientific Aviation, Inc. (“Scientific”), a provider of site-specific and regional methane emissions monitoring solutions for continuous and periodic monitoring applications. Under the terms of the agreement, we paid an initial amount of $10.0 million. We may also be required to make future payments of up to an additional $10.0 million, contingent on the future performance of Scientific.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s discussion and analysis is our analysis of our financial performance, financial condition and significant trends that may affect our future performance. It should be read in conjunction with the condensed consolidated financial statements, and notes thereto, included elsewhere in this report. It contains forward-looking statements including, without limitation, statements relating to ChampionX’s plans, strategies, objectives, expectations and intentions that are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by the words “believe,” “anticipate,” “expect,” “may,” “intend,” “foresee,” “guidance,” “estimate,” “potential,” “outlook,” “plan,” “should,” “would,” “could,” “target,” “forecast” and similar expressions, including the negative thereof. We undertake no obligation to publicly update, revise or correct any of our forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required under the federal securities laws. Readers are cautioned that such forward-looking statements should be read in conjunction with the disclosures under the heading “CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS.”

In November 2020, the U.S. Securities and Exchange Commission (the “SEC”) adopted the final rule under SEC Release No. 33-10890, Management’s Discussion and Analysis, Selected Financial Data, and Supplementary Financial Information, to modernize and simplify Management’s Discussion and Analysis and certain financial disclosure requirements. The final rule became effective on February 10, 2021 and must be applied in a registrant’s first fiscal year ending on or after August 9, 2021, however, under applicable SEC rules, early adoption is permitted following the effective date. We have elected to early adopt these amendments, including the sequential discussion of results within this section. Given the cyclical nature of our industry over the past decade combined with the short-cycle nature of our North American business, we believe this sequential discussion provides a more relevant analysis of our business results.

EXECUTIVE OVERVIEW AND BUSINESS OUTLOOK

We are a global leader in chemistry solutions and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely and efficiently around the world. Our products provide efficient and safe operations throughout the lifecycle of a well with a focus on the production phase of wells. Our business is organized into four reportable segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.

On June 3, 2020, the Company and Ecolab Inc. completed a Reverse Morris Trust transaction in which we acquired the Chemical Technologies business. In association with the completion of the Merger, the Company has changed its name from Apergy Corporation to ChampionX Corporation and its ticker symbol to “CHX”. See Note 2—Merger Transaction to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information.

On July 2, 2021, we acquired Scientific Aviation, Inc. (“Scientific”), a market leader in site-specific and regional methane emissions monitoring solutions for continuous and periodic monitoring applications. Under the terms of the agreement, we paid an initial amount of $10.0 million. We may also be required to make future payments of up to an additional $10.0 million, contingent on the future performance of Scientific.

Business Environment

We focus on economic- and industry-specific drivers and key risk factors affecting our business segments as we formulate our strategic plans and make decisions related to allocating capital and human resources. Our business segments provide a broad range of technologies and products for the oil and gas drilling, production and midstream industries and, as a result, are substantially dependent upon production and activity levels in the oil and gas and midstream industries. Demand for our products, technologies and services is impacted by overall global demand for oil and gas, ongoing depletion rates of existing wells which produce oil and gas, and our customers’ willingness to invest in the development and ongoing production of oil and gas resources. Our customers determine their operating and capital budgets based on current and expected future crude oil and natural gas prices, U.S. and worldwide rig count and U.S. well completions, among other factors. Crude oil and natural gas prices are impacted by supply and demand, which are influenced by geopolitical, macroeconomic, and local events, and have historically been subject to substantial volatility and cyclicality. Rig count, footage drilled, and exploration and production (E&P) investment by oil and gas operators have often been used as leading indicators for the level of drilling and development activity in the oil and gas sector.

Market Conditions and Outlook

The novel coronavirus (“COVID-19”) pandemic significantly disrupted the market with unprecedented fluctuations in the supply and demand of crude oil and resulting rapid decline of oil prices during 2020. In response to the significant reduction in oil prices, customer spending for exploration and production (E&P) activity deteriorated at a rapid pace due to reduced drilling activities, lower budgeted capital spending and options to reduce operating expenditures via cost cutting initiatives.

As the global economy reopened from the COVID-19 lockdowns, there has been an increase in demand which resulted in increased crude oil prices, reaching a two year high during the second quarter of 2021. Additionally, rig counts continue to increase, particularly in the U.S., amid the oil demand recovery. During the early months of 2021, we experienced a severe winter storm in Texas, which disrupted our operations due to facility damages and outages and raw materials supply chain disruptions. These factors led to short-term raw materials cost inflation during the first and second quarter of 2021. Although we continue to experience positive momentum within the industry, revenue is not growing at the same rate as the increase in activity. As many producers, particularly in the U.S., were faced with significant cash constraints during the pandemic, our customers continue to prioritize capital investment discipline and focus on using cash toward debt reduction and deleveraging their balance sheet. However, we expect positive momentum in our shorter-cycle North American businesses as well as a seasonal uptick in our international operations, particularly resulting from the recent OPEC production restorations, during the second half of the year.

CRITICAL ACCOUNTING ESTIMATES

Refer to our “Critical Accounting Estimates” included in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2020, for a discussion of our critical accounting estimates.

CONSOLIDATED RESULTS OF OPERATIONS


	Three Months Ended
	June 30,		March 31,		Variance
(dollars in thousands)	2021		2021		$
Revenue	$	749,172	$	684,888	$	64,284
Cost of goods and services	569,167		522,556		46,611
Gross profit	180,005		162,332		17,673
Selling, general and administrative expense	152,341		143,478		8,863


Interest expense, net	14,064		13,971		93
Other (income) expense, net	2,251		(1,936)		4,187
Income (loss) before income taxes	11,349		6,819		4,530
Provision for (benefit from) income taxes	3,563		2,782		781
Net income (loss)	7,786		4,037		3,749
Net income (loss) attributable to noncontrolling interest	536		(1,735)		2,271
Net income (loss) attributable to ChampionX	$	7,250	$	5,772	$	1,478

Revenue. Revenue increased $64.3 million, or 9%, as we posted sequential improvements across all operating segments. Within our Chemical Technologies business, the increase reflects recovery from the impact of the severe winter storm during the first quarter and a seasonal increase in our international operations. Production & Automation Technologies and Drilling Technologies segments have also increased as a result of an increase in U.S. land-based rig count and associated increase in customer spending on drilling activities, which positively impacted sales volumes.

Gross profit. Gross profit increased $17.7 million, or 11%, due to an increase in revenue and correlation between an increase in cost of materials associated with the higher volumes noted above.

Selling, general and administrative expense. Selling, general and administrative expense increased $8.9 million, or 6%, sequentially primarily due to integration related costs associated with the Merger and restructuring expenses incurred for employee severance and related benefits.

Provision for (benefit from) income taxes. Our provision for (benefit from) income taxes reflected effective tax rates of 31.4% and 40.8%, for the three months ended June 30, 2021 and March 31, 2021, respectively. The effective tax rate for the second quarter of 2021 was primarily impacted by the effects of valuation allowances in loss-making jurisdictions and withholding taxes.

CONSOLIDATED RESULTS OF OPERATIONS


	Six Months Ended
	June 30,				Variance
(dollars in thousands)	2021		2020		$
Revenue	$	1,434,060	$	560,348	$	873,712
Cost of goods and services	1,091,723		445,779		645,944
Gross profit	342,337		114,569		227,768
Selling, general and administrative expense	295,819		208,800		87,019
Goodwill impairment	—		616,271		(616,271)
Long-lived asset impairment	—		40,980		(40,980)
Interest expense, net	28,035		20,301		7,734
Other (income) expense, net	315		(1,321)		1,636
Income (loss) before income taxes	18,168		(770,462)		788,630
Provision for (benefit from) income taxes	6,345		(27,960)		34,305
Net income (loss)	11,823		(742,502)		754,325
Net income attributable to noncontrolling interest	(1,199)		871		(2,070)
Net income (loss) attributable to ChampionX	$	13,022	$	(743,373)	756,395

Revenue. Revenue increased $873.7 million for the six months ended June 30, 2021 compared to prior year due to $777.2 million of incremental revenues associated with our acquired Chemicals Technologies business. Additionally, Production & Automation Technologies revenue increased $34.8 million year-over-year, driven by higher volumes in North America and internationally as the global economy has rebounded from the COVID-19 pandemic.

Gross profit. Gross profit increased $227.8 million for the six months ended June 30, 2021 compared to prior year, mainly due to $187.2 million of gross profit generated by the acquired Chemicals Technologies business, further supplemented by cost savings from restructuring actions as well as other cost reduction efforts in response to the COVID-19 pandemic.

Selling, general and administrative expense. Selling, general and administrative expense increased $87.0 million, or 42%, for the six months ended June 30, 2021 compared to prior year, primarily due to $133.3 million of incremental expense associated with the acquired Chemicals Technologies business as well as the restoration of salaries from the temporary employee salary and benefit reduction instituted during 2020 to address the COVID-19 pandemic impact on commodity prices and oil and gas production. These increases were partially offset by fewer acquisition and integration related costs on the acquisition of Chemical Technologies.

Interest expense, net. Interest expense, net increased $7.7 million, or 38%, or the six months ended June 30, 2021 compared to prior year due to incremental interest expense related to the term loan assumed as part of the Merger, partially offset by a $68.4 million reduction in long-term debt during 2021.

Provision for (benefit from) income taxes. The effective tax rates for the first six months of 2021 and 2020 were 34.9% and 3.6% respectively. The effective tax rate for the first six months of 2021 was primarily due to the tax effects of valuation allowances in loss making jurisdictions and withholding taxes. The effective tax rate for the first six months of 2020 was primarily impacted by the tax effects of impairment of non-taxable goodwill of $560.1 million, recognized as a discrete item. Other items impacting the rate include the effects of valuation allowances in loss jurisdictions and foreign branch earnings.

SEGMENT RESULTS OF OPERATIONS


	Three Months Ended
	June 30,		March 31,		Variance
(dollars in thousands)	2021		2021		$
Segment revenue:
Production Chemical Technologies	$	447,049	$	412,371	$	34,678
Production & Automation Technologies	188,173		166,845		21,328
Drilling Technologies	37,589		34,994		2,595
Reservoir Chemical Technologies	33,222		29,891		3,331
Corporate	43,139		40,787		2,352
Total revenue	$	749,172	$	684,888	$	64,284

Segment operating profit (loss):
Production Chemical Technologies	$	33,871	$	30,357	$	3,514
Production & Automation Technologies	12,292		5,362		6,930
Drilling Technologies	3,868		6,386		(2,518)
Reservoir Chemical Technologies	(2,594)		(3,228)		634
Total segment operating profit (loss)	47,437		38,877		8,560
Corporate expense and other	22,024		18,087		3,937
Interest expense, net	14,064		13,971		93
Income (loss) before income taxes	$	11,349	$	6,819	$	4,530

Production Chemical Technologies

Revenue. Production Chemical Technologies revenue increased $34.7 million, or 8%, sequentially mainly due to the seasonal increase within our international operations as well as an increase in volumes in North America as we recovered from the impacts of the severe winter storm in the first quarter of 2021. Additionally, increased global pricing mitigated the increase in costs for raw materials and inflationary factors.

Operating profit. Production Chemical Technologies operating profit increased $3.5 million in the second quarter of 2021 compared to the prior quarter primarily due to higher revenue noted above and the correlating increase in cost of materials.

Production & Automation Technologies

Revenue. Production & Automation Technologies revenue increased $21.3 million, or 13%, as compared to the prior quarter, primarily due to an increase in customer spending as a result of improving market conditions during the second quarter of 2021. The increase in customer spending led to higher volumes across our product offerings in North America.

Operating profit. Production & Automation Technologies operating profit increased $6.9 million in the second quarter of 2021 compared to the prior quarter primarily due to higher sales volume as noted above.

Drilling Technologies

Revenue. Drilling Technologies revenue increased $2.6 million, or 7%, in the second quarter of 2021 compared to the prior quarter primarily due to an increase in U.S. land-based rig count and associated increase in customer spending on drilling activities, which positively impacted sales volumes of our diamond cutters and diamond bearings products.

Operating profit. Drilling Technologies operating profit decreased $2.5 million in the second quarter of 2021 compared to the prior quarter primarily due to higher professional fees associated with the defense of our patented technologies.

Reservoir Chemical Technologies

Revenue. Reservoir Chemical Technologies revenue increased $3.3 million, or 11%, sequentially mainly due to an increase in revenue within North America as we rebounded from the impact of the severe winter storm in the first quarter of 2021.

Operating profit. Reservoir Chemical Technologies operating loss was $2.6 million in the second quarter of 2021, relatively flat on a sequential basis, primarily due to continued raw material constraint.


	Six Months Ended June 30,				Variance
(dollars in thousands)	2021		2020		$
Segment revenue:
Production Chemical Technologies	$	859,420	$	136,002	$	723,418
Production & Automation Technologies	355,018		320,220		34,798
Drilling Technologies	72,583		76,903		(4,320)
Reservoir Chemical Technologies	63,113		9,306		53,807
Corporate	83,926		17,917		66,009
Total revenue	$	1,434,060	$	560,348	$	873,712

Segment operating profit (loss):
Production Chemical Technologies	$	64,228	$	9,922	$	54,306
Production & Automation Technologies	17,654		(685,759)		703,413
Drilling Technologies	10,254		7,548		2,706
Reservoir Chemical Technologies	(5,822)		(2,811)		(3,011)
Total segment operating profit (loss)	86,314		(671,100)		757,414
Corporate expense and other	40,111		79,061		(38,950)
Interest expense, net	28,035		20,301		7,734
Income (loss) before income taxes	$	18,168	$	(770,462)	$	788,630

The results of operations of the Production Chemical Technologies and Reservoir Chemical Technologies segments have been reflected in the table above from the closing date of the Merger through the end of the period presented. As results are not comparable for the given periods, no further discussion included herein.

Production & Automation Technologies

Revenue. Revenue increased $34.8 million, or 11%, as compared to the prior year, primarily due to an increase in customer spending as a result of improving market conditions during the first half of 2021. The increase in customer spending led to higher volumes across our product offerings in North America.

Operating profit. Operating profit increased $703.4 million compared to the prior year primarily due to goodwill and long-lived asset impairment charges of $657.3 million recognized during the six months ended June 30, 2020. Absent the impairment charges, operating profit increased due to the increase in revenue.

Drilling Technologies

Revenue. Revenue decreased $4.3 million, or 6%, compared to the prior year primarily due to a steep decline in U.S. land-based rig count throughout 2020 as a result of the pandemic. This resulted in a decline in customer spending on drilling activities, which negatively impacted sales volumes of our diamond cutters and diamond bearings products. Although we are experiencing an increase in rig counts sequentially, they have not reached pre-pandemic levels.

Operating profit. Operating profit increased $2.7 million, or 36%, compared to the prior year period despite lower revenue which was offset by cost savings from restructuring actions as well as other cost reduction efforts taken during 2020.

CAPITAL RESOURCES AND LIQUIDITY

Overview

Our primary source of cash is from operating activities. We have historically generated, and expect to continue to generate, positive cash flow from operations. Cash generated from operations is generally allocated to working capital requirements, investments to support profitable revenue growth and maintain our facilities and systems, acquisitions that create value through add-on capabilities that broaden our existing businesses and deliver our growth strategy, as well as debt repayments to reduce our leverage.

At June 30, 2021, we had cash and cash equivalents of $239.0 million compared to $201.4 million at December 31, 2020, primarily for working capital and operational purposes. At June 30, 2021, we had total liquidity of $591.9 million, comprised of $239.0 million of cash and $352.9 million of available capacity on our revolver.

At June 30, 2021, we had a long-term debt balance of $838.8 million, net of the current portion of long-term debt of $26.9 million, primarily consisting of our term loan due 2027 with a principal amount of $510.2 million, our Senior Notes due in 2026 with a principal amount of $222.0 million, and our term loan due in 2025 with a principal amount of $140.0 million. We also have access to a revolving credit facility which expires in May of 2023, which had an unused capacity of $352.9 million at June 30, 2021.

Outlook

We expect to generate cash to support liquidity and business requirements through operations and, if necessary, through our revolving credit facility. Volatility in credit, equity and commodity markets can create uncertainty for our businesses. However, the Company believes, based on our current financial condition and current expectations of future market conditions, that we will meet our short- and long-term needs with a combination of cash on hand, cash generated from operations, our revolving credit facility and access to capital markets.

In 2021, we expect to fund our capital expenditures and reduce outstanding debt through earnings and working capital improvements. We project capital expenditures of 3.0% to 3.5% of revenue inclusive of capital investments for our electric submersible pump leased assets.

Information related to guarantees is incorporated herein by reference from Note 7—Commitments And Contingencies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Cash Flows


	Six Months Ended June 30,
(in thousands)	2021		2020
Cash provided by operating activities	$	151,138	$	78,033
Cash (used in) provided by investing activities	(43,198)		39,332
Cash used in financing activities	(69,743)		(9,970)
Effect of exchange rate changes on cash and cash equivalents	(623)		(790)
Net increase (decrease) in cash and cash equivalents	$	37,574	$	106,605

Operating Activities

Cash provided by operating activities during the six months ended June 30, 2021 increased $73.1 million compared to 2020. The increase in cash provided by operating activities was primarily driven by an increase in our results of operations. The results of our Chemicals Technologies business include six months of activity in 2021 as compared to 2020 including the period

from the acquisition date of June 3, 2020 through the end of the period. Changes in working capital items used cash of $7.5 million during the six months ended June 30, 2021 compared to cash generated of $77.2 million during 2020. The change in working capital items primarily related to cash outflows for inventory procurement and an increase in accounts receivable as a result of revenue growth during the period.

Expenditures for assets that are placed into our lease asset program expected to be recovered through sale are reported in leased assets in the operating section of our condensed consolidated statements of cash flows. All other capitalizable expenditures for assets that are placed into our lease asset program are classified as capital expenditures in the investing section of our condensed consolidated statements of cash flows.

Investing Activities

Cash used in investing activities was $43.2 million for the six months ended June 30, 2021, and was primarily comprised of capital expenditures of $45.7 million, partially offset by $2.5 million of cash proceeds from the sale of fixed assets.

Cash provided by investing activities was $39.3 million for the six months ended June 30, 2020, and was primarily comprised of cash acquired in the Merger of $57.6 million and $1.1 million of cash proceeds from the sale of fixed assets, partially offset by capital expenditures of $19.3 million.

Financing Activities

Cash used in financing activities of $69.7 million for the six months ended June 30, 2021, was primarily the result of repayments totaling $71.1 million on long-term debt, $2.6 million of payments of finance lease obligations and a distribution of $0.8 million to one of our non-controlling interests. This was partially offset by $6.5 million in cash proceeds from the exercise of stock options.

Cash used in financing activities of $10.0 million for the six months ended June 30, 2020, was primarily the result of $4.4 million in debt issue costs related to the amendment of the credit agreement and payments totaling $2.8 million for finance lease obligations.

Revolving Credit Facility

A summary of our revolving credit facility at June 30, 2021, was as follows:


(in millions) Description	Amount		Debt Outstanding		Letters of Credit		Unused Capacity		Maturity
Five-year revolving credit facility	$	400.0	$	—	$	47.1	$	352.9	May 2023

Additionally, we have a letter of credit outside of the revolving credit facility of approximately $1.9 million. As of June 30, 2021, we were in compliance with all restrictive covenants under our revolving credit facility.

Pursuant to Section 15(d) of the Securities Exchange Act of 1934, the obligation to file periodic financial information of the wholly owned subsidiaries of the Company that guarantee the Senior Notes was automatically suspended on January 1, 2021 when the Senior Notes were held by fewer than 300 persons.

RECENTLY ISSUED ACCOUNTING STANDARDS

See Note 1—Basis Of Presentation And Summary Of Significant Accounting Policies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We may be exposed to certain market risks arising from the use of financial instruments in the ordinary course of business. For quantitative and qualitative disclosures about market risk, see Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our Annual Report on Form 10-K for the year ended December 31, 2020. Our exposure to market risk has not materially changed since December 31, 2020.

ITEM 4. CONTROLS AND PROCEDURES

With the participation of management, our principal executive officer and principal financial officer carried out an evaluation, pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of June 30, 2021.

There were no changes in internal control over financial reporting identified in the evaluation for the quarter ended June 30, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are involved in various pending or potential legal actions in the ordinary course of our business. Management is unable to predict the ultimate outcome of these actions because of the inherent uncertainty of litigation. However, management believes the most probable, ultimate resolution of these matters will not have a material adverse effect on our condensed consolidated financial position, results of operations or cash flows. See Note 7—Commitments And Contingencies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

ITEM 1A. RISK FACTORS

There have been no material changes or updates to our risk factors that were previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

(a)None.

(b)None.

(c)None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Iran Threat Reduction and Syria Human Rights Act of 2012

Under the Iran Threat Reduction and Syria Human Rights Act of 2012, which added Section 13(r) of the Securities Exchange Act of 1934, the Company is required to disclose in its periodic reports if it or any of its affiliates knowingly engaged in certain activities, transactions or dealings relating to Iran or with entities or individuals designated pursuant to certain Executive Orders. Disclosure is required even where the activities are conducted outside the U.S. by non-U.S. affiliates in compliance with applicable law, and even if the activities are not covered or prohibited by U.S. law.

As authorized by the U.S. Treasury’s Office of Foreign Assets Control (OFAC), a non-U.S. subsidiary of the Company which is part of Chemical Technologies completed sales of products used for process and water treatment applications in upstream oil and gas production related to the operation of and production from the Rhum gas field off the Scottish coast (Rhum) totaling $145,874 during the period from April 1, 2021 to June 30, 2021. The net profit before taxes associated with these sales for each period were nominal. Rhum is jointly owned by Serica Energy plc and Iranian Oil Company (U.K.) Limited. Our non-U.S. subsidiary intends to continue the Rhum-related activities, consistent with a specific license obtained from OFAC by its customers, and such activities may require additional disclosure pursuant to the above mentioned statute.

ITEM 6. EXHIBITS



Exhibit No.						Exhibit Description

10.1+						ChampionX Corporation Amended and Restated 2018 Equity and Cash Incentive Plan effective as of February 18, 2021 (incorporated by reference to Exhibit 10.1 to ChampionX’s Current Report on Form 8-K filed May 13, 2021)
31.1*						Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
31.2*						Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
32.1**						Certification of Chief Executive Officer Under Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350.
32.2**						Certification of Chief Financial Officer Under Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350.
101.INS*						XBRL Instance Document
101.SCH*						XBRL Taxonomy Extension Schema Document
101.CAL*						XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*						XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*						XBRL Taxonomy Extension Label Linkbase Document
101.PRE*						XBRL Taxonomy Extension Presentation Linkbase Document
104*						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Filed herewith
** Furnished herewith
† Denotes management contract or compensatory plan or arrangement

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


CHAMPIONX CORPORATION
(Registrant)

/s/ ANTOINE MARCOS
Antoine Marcos
Vice President, Corporate Controller and Chief Accounting Officer
(Principal Accounting Officer and a Duly Authorized Officer)

Date:			July 29, 2021

Document

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Sivasankaran Somasundaram, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of ChampionX Corporation (the “registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:

July 29, 2021

/s/ SIVASANKARAN SOMASUNDARAM

Sivasankaran Somasundaram

President and Chief Executive Officer

(Principal Executive Officer)

Document

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Kenneth M. Fisher, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of ChampionX Corporation (the “registrant”);

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:

July 29, 2021

/s/ KENNETH M. FISHER

Kenneth M. Fisher

Executive Vice President and
Chief Financial Officer

(Principal Financial Officer)

Document

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

UNDER SECTION 906 OF THE SARBANES-OXLEY

ACT OF 2002, 18 U.S.C. SECTION 1350

I, Sivasankaran Somasundaram, President and Chief Executive Officer of ChampionX Corporation (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(a) The Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2021, as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:

July 29, 2021

/s/ SIVASANKARAN SOMASUNDARAM

Sivasankaran Somasundaram

President and Chief Executive Officer

(Principal Executive Officer)

Document

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

UNDER SECTION 906 OF THE SARBANES-OXLEY

ACT OF 2002, 18 U.S.C. SECTION 1350

I, Kenneth M. Fisher, Executive Vice President and Chief Financial Officer of ChampionX Corporation (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:

July 29, 2021

/s/ KENNETH M. FISHER

Kenneth M. Fisher

Executive Vice President and
Chief Financial Officer

(Principal Financial Officer)